CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells

Isabella Barbutti; Juliana M. Xavier-Ferrucio; João Agostinho Machado-Neto; Lauremilia Ricon; Fabiola Traina; Stefan K. Bohlander; Sara Teresinha Olalla Saad; Leticia Fröhlich Archangelo

doi:10.18632/oncotarget.11724

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells

Isabella Barbutti, Juliana M. Xavier-Ferrucio, João Agostinho Machado-Neto, Lauremilia Ricon, Fabiola Traina, Stefan K. Bohlander, Sara Teresinha Olalla Saad and Leticia Fröhlich Archangelo _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:68385-68396. https://doi.org/10.18632/oncotarget.11724

Metrics: PDF 1855 views | HTML 3760 views | ?

Abstract

Isabella Barbutti1, Juliana M. Xavier-Ferrucio1,*, João Agostinho Machado-Neto1,#, Lauremilia Ricon1, Fabiola Traina2, Stefan K. Bohlander3, Sara Teresinha Olalla Saad1, Leticia Fröhlich Archangelo1,4

1Hematology and Hemotherapy Center, State University of Campinas (UNICAMP), Carlos Chagas 480, Campinas-SP, Brazil

2Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

3Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand

4Department of Cellular and Molecular Biology and Pathogenic Bioagents, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

*Present address: Department of Laboratory Medicine, Yale Stem Cell Center

#Present address: Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

Correspondence to:

Leticia Fröhlich Archangelo, email: [email protected]

Keywords: CATS (FAM64A), proliferation, clonogenicity, CALM/AF10, leukemogenesis

Received: November 10, 2015 Accepted: August 21, 2016 Published: August 31, 2016

ABSTRACT

The CATS (FAM64A) protein interacts with CALM (PICALM) and the leukemic fusion protein CALM/AF10. CATS is highly expressed in leukemia, lymphoma and tumor cell lines and its protein levels strongly correlates with cellular proliferation in both malignant and normal cells. In order to obtain further insight into CATS function we performed an extensive analysis of CATS expression during differentiation of leukemia cell lines. While CATS expression decreased during erythroid, megakaryocytic and monocytic differentiation, a markedly increase was observed in the ATRA induced granulocytic differentiation. Lentivirus mediated silencing of CATS in U937 cell line resulted in somewhat reduced proliferation, altered cell cycle progression and lower migratory ability in vitro; however was not sufficient to inhibit tumor growth in xenotransplant model. Of note, CATS knockdown resulted in reduced clonogenicity of CATS-silenced cells and reduced expression of the self-renewal gene, GLI-1. Moreover, retroviral mediated overexpression of the murine Cats in primary bone marrow cells lead to decreased colony formation. Although our in vitro data suggests that CATS play a role in cellular processes important for tumorigenesis, such as cell cycle control and clonogenicity, these effects were not observed in vivo.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11724

Publication Alerts

Research Papers:

CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells

Abstract